Goodrx Holdings Inc (OQ:GDRX)

Business Focus: Internet Services

Apr 23, 2024 05:30 pm ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ:GDRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Apr 23, 2024 04:27 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange...
Apr 23, 2024 02:30 pm ET
GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
Bernstein Liebhard LLP: Do you, or did you, own shares of GoodRx Holdings, Inc. (NASDAQ: GDRX)?Did you purchase your shares between September 23, 2020 and November 8, 2022, inclusive?Did you lose money in your investment in GoodRx Holdings,...
Apr 23, 2024 02:12 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. (GDRX)
Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired GoodRx Holdings,...
Apr 23, 2024 09:20 am ET
NASDAQ: GDRX: Kessler Topaz Meltzer & Check, LLP Files a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) (“GoodRx” or the “Company”) on behalf of investors who purchased or...
Apr 11, 2024 04:09 pm ET
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacif
Mar 14, 2024 08:00 am ET
GoodRx Interim CEO Extends Commitment to Company
GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced Interim CEO Scott Wagner has extended his commitment to the Company. In addition, Stephen LeSieur and Adam Karol have notified GoodRx of their decision to resign from the Company’s Board of Directors, effective March 14, 2024 and March 22, 2024, respectively.
Feb 29, 2024 06:02 am ET
GoodRx Reports Fourth Quarter and Full Year 2023 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024.
Feb 20, 2024 04:05 pm ET
GoodRx to Participate in Upcoming Investor Conferences
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences:
Feb 01, 2024 04:05 pm ET
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Thursday, February 29, 2024. GoodRx management will also hold a conference call and webcast that mornin
Jan 22, 2024 02:15 pm ET
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities.
Jan 11, 2024 09:00 am ET
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company’s impact on social welfare as a result of helping millions of people access affordable medications. “
Jan 10, 2024 09:01 am ET
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings, today provided preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.
Dec 22, 2023 09:00 am ET
GoodRx Appoints Kelly J. Kennedy to Board of Directors
GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the election of Kelly J. Kennedy to its Board of Directors. Kennedy will serve as a member of the Board’s audit committee and fill the seat left vacant by Jacqueline Kosecoff earlier this year.
Dec 13, 2023 04:05 pm ET
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time).
Nov 16, 2023 04:05 pm ET
GoodRx to Participate in the Evercore ISI HealthCONx Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, FL on Thursday, November 30, 2023 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time).
Nov 09, 2023 06:02 am ET
GoodRx Reports Third Quarter 2023 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, has released its financial results for the third quarter 2023.
Oct 19, 2023 09:00 am ET
GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi
Oct 12, 2023 04:05 pm ET
GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 financial results before U.S. markets open on Thursday, November 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pac
Oct 12, 2023 09:00 am ET
GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and Navitus Health Sol
Sep 21, 2023 09:00 am ET
 GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is offering
Sep 13, 2023 09:00 am ET
GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and MedImpact, the independent pharmac
Sep 11, 2023 09:00 am ET
GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200 prescription medications by an average of 40%, with even greater savings available for select medications. Consumers can now purchase many popular prescriptions at Walgreens for less than $15 for a 30-day
Aug 30, 2023 04:05 pm ET
GoodRx to Present at the Morgan Stanley Global Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will be presenting at the Morgan Stanley Global Healthcare Conference in New York, NY on Wednesday, September 13, 2023 at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).
Aug 30, 2023 06:00 am ET
GoodRx Launches Real-Time Benefit Check In Provider Mode To Offer Comprehensive Cost Information At The Point of Prescribing
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced the launch of
Aug 09, 2023 06:01 am ET
GoodRx Reports Second Quarter 2023 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, has released its financial results for the second quarter 2023.
Jul 27, 2023 09:00 am ET
GoodRx Unveils Medicine Cabinet, A Better Way To Manage All Of Your Prescriptions
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced M
Jul 12, 2023 04:05 pm ET
GoodRx Announces Date for Second Quarter 2023 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading resource for healthcare savings and information, today announced it will release its second quarter 2023 financial results before U.S. markets open on Wednesday, August 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pac
Jul 12, 2023 06:00 am ET
CVS Caremark and GoodRx to launch Caremark® Cost Saver™ to help lower out-of-pocket drug costs for CVS Caremark clients' members
Prescription drug discount solution to help lower costs, improve experience for tens of millions of CVS Caremark clients' members
Jul 10, 2023 09:00 am ET
GoodRx Appoints Dorothy Gemmell as Chief Commercial Officer
GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the appointment of Dorothy Gemmell as Chief Commercial Officer, effective July 3, 2023. Gemmell will work closely with Aaron Crittenden, newly appointed Chief Revenue Officer, and together they will lead the company’s Pharma Manufacturer Solutions business, which provides solutions for pharmaceutical and medical device companies.
May 25, 2023 04:05 pm ET
GoodRx to Present at the Jefferies Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Jefferies Healthcare Conference in New York, NY on Thursday, June 8, 2023 at 12:30 p.m. Pacific Time (3:30 p.m. Eastern Time).
May 10, 2023 06:02 am ET
GoodRx Reports First Quarter 2023 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, has released its financial results for the first quarter 2023.
Apr 27, 2023 04:05 pm ET
GoodRx to Present at the BofA Securities 2023 Health Care Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Thursday, May 11, 2023 at 9:20 a.m. Pacific Time (12:20 p.m. Eastern Time).
Apr 25, 2023 04:15 pm ET
GoodRx Expands Executive Team With New Interim CEO
GoodRx Holdings, Inc. (NASDAQ: GDRX), a leading digital healthcare platform, today announced that Scott Wagner has been appointed Interim Chief Executive Officer, effective April 25, 2023. Co-founders Doug Hirsch and Trevor Bezdek have transitioned into new roles as Chief Mission Officer and Chairman, respectively. Wagner will work closely with Hirsch and Bezde
Apr 12, 2023 04:05 pm ET
GoodRx Announces Date for First Quarter 2023 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, today announced it will release its first quarter 2023 financial results before U.S. markets open on Wednesday, May 10, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Ea
Feb 28, 2023 04:07 pm ET
GoodRx Reports Fourth Quarter and Full Year 2022 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, has released its financial results for the fourth quarter and full year 2022.
Feb 21, 2023 04:05 pm ET
GoodRx to Present at the Cowen 43rd Annual Health Care Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Cowen 43rd Annual Health Care Conference in Boston, MA on Tuesday, March 7, 2023 at 6:50 a.m. Pacific Time (9:50 a.m. Eastern Time).
Jan 31, 2023 04:05 pm ET
GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to dis
Dec 21, 2022 04:05 pm ET
GoodRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2023 at 3:45 p.m. Pacific Time (6:45 p.m. Eastern Time).
Nov 08, 2022 04:07 pm ET
GoodRx Reports Third Quarter 2022 Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital platform, has released its financial results for the third quarter of 2022.
Nov 03, 2022 07:00 am ET
New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe
GoodRx (NASDAQ: GDRX), a leading consumer-focused digital healthcare platform, today released a
Oct 27, 2022 04:05 pm ET
GoodRx to Present at Upcoming Investor Conferences
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the following investor conferences:
Oct 13, 2022 09:00 am ET
GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®
GoodRx (NASDAQ: GDRX), a leading consumer-focused digital healthcare platform, today announced a collaboration with
Oct 13, 2022 09:00 am ET
GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the launch of
Oct 11, 2022 04:05 pm ET
GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its third quarter 2022 financial results after U.S. markets close on Tuesday, November 8, 2022. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to di
Oct 04, 2022 09:00 am ET
GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it is offering free online healthcare provider visits to Florida residents impacted by Hurricane Ian. Now through October 17, Florida residents can visit
Aug 29, 2022 04:05 pm ET
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time).
Aug 09, 2022 09:31 am ET
Thinking about buying stock in GoodRx, Nielsen, Edgio, Lemonade, or BBQ?
NEW YORK, Aug. 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GDRX, NLSN, EGIO, LMND, and BBQ.
Aug 08, 2022 04:07 pm ET
GoodRx Releases Second Quarter 2022 Financial Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, has released its second quarter 2022 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
Aug 04, 2022 01:35 pm ET
GoodRx Offers Free Telehealth Appointments to Kentucky Residents Affected by Flooding
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it is offering free online healthcare provider visits to Kentucky residents impacted by local flooding. Now through the end of August, Kentuckians can visit
Jul 27, 2022 08:00 am ET
GoodRx to Present Virtually at the Bank of America SMID Cap Ideas Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that management from the Company will be presenting virtually at the Bank of America SMID Cap Ideas Conference on Wednesday, August 10, at 8:20 a.m. Pacific Time (11:20 a.m. Eastern Time).
Jul 15, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, GoodRx, and the WWE and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (NASDAQ: TGTX), Allianz SE (OTCMKTS: ALIZY), GoodRx Holdings, Inc. (NASDAQ: GDRX), and World Wrestling...
Jul 11, 2022 08:00 am ET
GoodRx Announces Date for Second Quarter 2022 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its second quarter 2022 financial results after U.S. markets close on Monday, August 8, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss t
Jul 10, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Allianz, TrueBlue, and GoodRx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allianz SE (OTCMKTS: ALIZY) TrueBlue, Inc. (NYSE: TBI), and GoodRx Holdings, Inc. (NASDAQ: GDRX). Our investigations concern...
Jul 04, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, the WWE, Digital World, and Generac and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX), World Wrestling Entertainment, Inc. (NYSE: WWE), Digital World Acquisition Corp....
Jun 29, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating TrueBlue, NeoGenomics, GoodRx, and Ebix and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TrueBlue, Inc. (NYSE: TBI), NeoGenomics, Inc. (NASDAQ: NEO), GoodRx Hodlings, Inc. (NASDAQ: GDRX), and Ebix, Inc. (NASDAQ:...
Jun 24, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Cassava, Ebix, and the WWE and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX), Cassava Sciences, Inc. (NASDAQ: SAVA), Ebix, Inc. (NASDAQ: EBIX), and World Wrestling...
Jun 03, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, GoodRx, Agrify, and Pegasystems and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (NASDAQ: TGTX), GoodRx Holdings, Inc. (NASDAQ: GDRX), Agrify Corporation (NASDAQ: AGFY), and...
Jun 02, 2022 06:48 pm ET
Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX). The investigation concerns whether GoodRx has violated the federal securities laws and/or engaged in...
Jun 01, 2022 07:14 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
LOS ANGELES, June 1, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) investors concerning the Company's possible violations of the federal securities laws.  
Jun 01, 2022 07:12 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
BENSALEM, Pa., June 1, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) investors concerning the Company's possible violations of federal securities laws.
Jun 01, 2022 07:10 pm ET
The Law Offices of Frank R. Cruz Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
LOS ANGELES, June 1, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) on behalf of investors concerning the Company's possible violations of federal securities laws.
May 27, 2022 02:18 pm ET
Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 22, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS: CLZNY), TG Therapeutics, Inc. (NASDAQ: TGTX), Coinbase Global, Inc. (NASDAQ: COIN), and GoodRx...
May 19, 2022 12:08 pm ET
Kirby McInerney LLP Continues Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX). The investigation concerns whether GoodRx has violated the federal securities laws and/or engaged in...
May 18, 2022 02:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 18, 2022 10:00 am ET
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
Law Offices of Howard G. Smith continues its investigation on behalf of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) investors concerning the Company’s possible violations of federal securities laws.
May 17, 2022 06:00 pm ET
The Law Offices of Frank R. Cruz Continues Its Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
The Law Offices of Frank R. Cruz continues its investigation of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 17, 2022 09:00 am ET
GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced a strategic relationship with
May 16, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS: CLZNY), TG Therapeutics, Inc. (NASDAQ: TGTX), Coinbase Global, Inc. (NASDAQ: COIN), and GoodRx...
May 12, 2022 09:00 pm ET
GOODRX ALERT: Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Inc. on Behalf of GoodRx Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) on behalf of GoodRx stockholders. Our investigation concerns whether GoodRx has violated the federal securities laws and/or engaged in other unlawful business practices.
May 12, 2022 02:22 pm ET
Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The law firm of Kirby McInerney LLP is investigating potential claims against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 11, 2022 05:15 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 11, 2022 03:15 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) investors concerning the Company’s possible violations of federal securities laws.
May 11, 2022 01:28 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
May 09, 2022 04:07 pm ET
GoodRx Releases First Quarter 2022 Financial Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, has released its first quarter 2022 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
May 02, 2022 04:05 pm ET
GoodRx to Present at the RBC Capital Markets 2022 Global Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the RBC Capital Markets 2022 Global Healthcare Conference in New York, NY on Tuesday, May 17, at 1:35 p.m. Eastern Time (10:35 a.m. Pacific Time).
May 02, 2022 06:00 am ET
GoodRx Teams Up with AssistRx to Increase Provider Awareness of Simplified Specialty Medication and Treatment Initiation
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced a new effort with AssistRx
Apr 14, 2022 04:05 pm ET
GoodRx Closes Acquisition of vitaCare, A Tech-Enabled Pharmacy Services Platform
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition will enable GoodRx to help more patients receive their prescriptions in an efficient, afforda
Apr 11, 2022 08:00 am ET
GoodRx Announces Date for First Quarter 2022 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its first quarter 2022 financial results after U.S. markets close on Monday, May 9, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the r
Mar 07, 2022 07:31 am ET
GoodRx Agrees to Acquire vitaCare, A Tech-Enabled Pharmacy Services Platform
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it has entered into a definitive agreement to acquire
Mar 01, 2022 10:00 am ET
Thinking about buying stock in Lucid Group, SoFi Technologies, Vale, IQIYI, or Goodrx?
NEW YORK, March 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, SOFI, VALE, IQ, and GDRX.
Feb 28, 2022 04:07 pm ET
GoodRx Announces $250 Million Share Repurchase Program
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to $250 million of its Class A Common Stock, effective immediately.
Feb 28, 2022 04:07 pm ET
GoodRx Releases Fourth Quarter and Full Year 2021 Financial Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, has released its fourth quarter and full year 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
Feb 22, 2022 04:05 pm ET
GoodRx to Present at Upcoming Investor Conferences
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the following investor conferences:
Jan 31, 2022 04:05 pm ET
GoodRx Announces Date for Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its fourth quarter and full year 2021 financial results after U.S. markets close on Monday, February 28, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern T
Jan 04, 2022 04:05 pm ET
GoodRx to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).
Nov 17, 2021 04:05 pm ET
GoodRx to Present at Upcoming Investor Conferences
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s digital resource for healthcare, today announced that executives from the Company will be presenting at the following investor conferences:
Nov 15, 2021 06:00 am ET
GoodRx Releases New Report Examining the State of Telehealth
GoodRx, Inc. (NASDAQ: GDRX), America’s digital resource for healthcare, today released a new report on the
Nov 10, 2021 04:07 pm ET
GoodRx Releases Third Quarter 2021 Financial Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), America’s digital resource for healthcare, has released its third quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
Oct 13, 2021 04:05 pm ET
GoodRx Announces Date for Third Quarter 2021 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s digital resource for healthcare, today announced it will release its third quarter 2021 financial results after U.S. markets close on Wednesday, November 10, 2021. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the resul
Oct 01, 2021 10:50 pm ET
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into GoodRx Holdings, Inc. (NasdaqGS: GDRX).
Sep 30, 2021 04:05 pm ET
GoodRx to Present at the Morgan Stanley Annual Spark Conference
GoodRx Holdings, Inc. (Nasdaq: GDRX), America’s digital resource for healthcare, today announced that executives from the Company will be presenting at the Morgan Stanley Annual Spark Conference in Beverly Hills, CA on Thursday, October 14, at 1:15 p.m. PT.
Sep 27, 2021 09:00 am ET
Fetch Rewards Names GoodRx Exclusive Prescription Savings Provider
GoodRx, Inc. (NASDAQ: GDRX), America’s digital resource for healthcare, and Fetch Rewards, America’s No. 1 rewards ap
Sep 23, 2021 09:00 am ET
GoodRx Launches GoodRx Health, A Next-Generation Online Health Resource
GoodRx (Nasdaq: GDRX), America’s digital resource for healthcare, today launched GoodRx Health to provide research
Sep 20, 2021 04:43 pm ET
GoodRx to Host Educational Webinar
GoodRx Holdings, Inc. (Nasdaq: GDRX), America’s digital resource for healthcare, today announced it will host GoodRx 101, a virtual educational webinar for analysts and investors, on Thursday, September 30, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time). At that time, GoodRx management will present an overview of the business.
Sep 10, 2021 10:50 pm ET
GOODRX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of GoodRx Holdings, Inc. - GDRX
NEW ORLEANS, La., Sept. 10, 2021 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into GoodRx Holdings, Inc. (NASDAQ: GDRX).  
Sep 08, 2021 12:43 pm ET
CORRECTING and REPLACING New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers
Third paragraph, last sentence of release should read: All told, healthcare professionals represent more than 17% of the people who visit the GoodRx website, based on a February 2020 website survey (instead of All told, healthcare professionals represent more than 17% of the people who visit the GoodRx website, based on a July 2021 website survey).
Sep 08, 2021 09:00 am ET
New Internal Survey Shows Strength of Relationship Between GoodRx and Healthcare Providers
GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today released the results of a July 2021 internal survey of healthcare providers who utilize GoodRx showing the positive and strong relationships the company has with healthcare professionals. Findings indicate providers believe that using GoodRx improves patient access to medicati
Aug 26, 2021 08:00 am ET
GoodRx to Present Virtually at Upcoming Investor Conferences
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences: Morgan Stanley 19th Annual Global Healthcare...
Aug 20, 2021 10:50 pm ET
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into GoodRx Holdings, Inc. (NasdaqGS: GDRX).
Aug 12, 2021 07:32 am ET
GoodRx Releases Second Quarter 2021 Financial Results
GoodRx Holdings, Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its second quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at...
Aug 09, 2021 09:00 am ET
GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
GoodRx, Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, and Boehringer Ingelheim, a privately owned, leading global biopharmaceutical company, today announced a new joint effort to increase access to patient savings programs...
Aug 05, 2021 09:00 am ET
GoodRx Announces Agreement with Surescripts to Provide Real-Time Drug Discount Pricing in Electronic Health Records
GoodRx (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced that it has entered into an agreement with Surescripts, the nation’s leading health information network, to deliver drug discount price information to...
Aug 03, 2021 09:00 am ET
GoodRx Savings Increase Pharmacy Visits and Customer Loyalty For Retailers
GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today shared the results of a recent consumer survey showing the company’s impact on pharmacy retailers. Findings indicate that GoodRx helps pharmacies boost sales by...
Jul 15, 2021 08:00 am ET
GoodRx Announces Date for Second Quarter 2021 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced it will release its second quarter 2021 financial results before U.S. markets open on Thursday, August 12, 2021. GoodRx management will hold a...
Jul 08, 2021 10:00 am ET
GoodRx and DoorDash Partner to Provide Dashers Nationwide with Access to GoodRx Gold
GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced a partnership with online food ordering and delivery platform
Jun 28, 2021 12:56 pm ET
Lifshitz Law Firm, P.C. Announces Investigations of GoodRx Holdings, Inc. (NasdaqGS: GDRX), Lordstown Motors Corp. (NasdaqGS: RIDE), Tricada, Inc. (NasdaqGS: TCDA), and XL Fleet Corp. (NYSE: XL)
GoodRx Holdings, Inc. (NasdaqGS: GDRX) Lifshitz Law Firm, P.C. announces that a class action complaint was filed against GDRX alleging that at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. was developing and would soon...
Jun 15, 2021 09:12 pm ET
The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare
GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, just released a new report that discusses the effect the company has had on the American healthcare system by helping patients afford their medications.
May 13, 2021 04:07 pm ET
GoodRx Releases First Quarter 2021 Financial Results
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its first quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
May 05, 2021 04:05 pm ET
GoodRx to Present Virtually at Upcoming Investor Conferences
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences:
May 05, 2021 03:33 pm ET
Shareholder Alert: Robbins LLP is Investigating GoodRx Holdings, Inc. (GDRX) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating GoodRx Holdings, Inc. (NASDAQ: GDRX) on behalf of shareholders to determine whether certain GoodRx officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. GoodRx is a holding company that owns and operates a U.S
Apr 27, 2021 09:00 am ET
GoodRx Announces Streamlined Access to Sanofi Savings Programs
GoodRx (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced an integrated offering with global biopharmaceutical company
Apr 19, 2021 09:00 am ET
GoodRx Expands Manufacturer Solutions Offering with Acquisition of HealthiNation
GoodRx, Inc. (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced the closing of the acquisition of
Apr 15, 2021 04:05 pm ET
GoodRx Announces Date for First Quarter 2021 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced it will release its first quarter 2021 financial results after U.S. markets close on Thursday, May 13, 2021. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the res
Mar 24, 2021 11:00 am ET
GoodRx Offers Largest Appointment Tracker for COVID-19 Vaccines
GoodRx (Nasdaq: GDRX), America’s leading resource for healthcare savings, is helping consumers navigate the roll-out of the COVID-19 vaccine with the launch of its
Mar 11, 2021 04:07 pm ET
GoodRx Releases Fourth Quarter and Full Year 2020 Financial Results
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its fourth quarter and full year 2020 financial results and posted a letter to shareholders on the Overview page of its investor relations website at
Mar 04, 2021 10:00 am ET
Feb 16, 2021 01:13 pm ET
GDRX FINAL DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline Today - GDRX
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021 lead plaintiff deadline.
Feb 16, 2021 09:43 am ET
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, Feb. 16, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Feb 12, 2021 11:15 am ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
The Law Offices of Frank R. Cruz reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Feb 12, 2021 10:00 am ET
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders...
Feb 11, 2021 05:45 pm ET
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors with Large Losses to Secure Counsel Before Important February 16 Deadline – GDRX
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16,...
Feb 11, 2021 04:05 pm ET
GoodRx Announces Date for Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading source of healthcare savings, today announced it will release its fourth quarter and full year 2020 financial results after U.S. markets close on Thursday, March 11, 2021. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to d
Feb 11, 2021 11:00 am ET
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:
Feb 10, 2021 12:30 pm ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 10, 2021 10:33 am ET
FEB 16 DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action, go...
Feb 10, 2021 08:30 am ET
GDRX CLASS ACTION DEADLINE ALERT: GoodRx Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) to determine whether the Company engaged in securities fraud or other unlawful business...
Feb 09, 2021 03:51 pm ET
GDRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Encourages Investors with Losses in Excess of $100,000 to Secure Counsel; Lead Pl
PHILADELPHIA, Feb. 9, 2021 /PRNewswire/ -- Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. ("GoodRx" or the "Company") on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the "Class Period"), and encourages investors with losses in excess of $100,000 to contact the firm.
Feb 08, 2021 11:35 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) securities between...
Feb 05, 2021 07:45 pm ET
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages GoodRx Holdings, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important February 16 Deadline – GDRX
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16,...
Feb 03, 2021 03:26 pm ET
GDRX INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.
Feb 03, 2021 03:18 pm ET
DEADLINE FEB 9 ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.– GDRX
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020, inclusive (the “Class Period”). The...
Feb 03, 2021 12:30 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or...
Feb 02, 2021 05:38 pm ET
BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - GDRX
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021 lead plaintiff deadline.
Feb 02, 2021 11:00 am ET
DEADLINE ALERT for CVIAQ, QIWI, KNDI, and GDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 02, 2021 11:00 am ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Feb 02, 2021 10:00 am ET
KNDI, QIWI & GDRX Approaching Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Shareholders to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Feb 01, 2021 01:12 pm ET
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Feb 01, 2021 10:30 am ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
BENSALEM, Pa., Feb. 1, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) Class A common stock between September 23, 2020 and November 16, 2020, inclusive (the "Class Period").
Jan 29, 2021 10:09 am ET
GDRX SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Jan 28, 2021 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
LOS ANGELES, Jan. 28, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) securities between September 23, 2020 and November 16, 2020, inclusive (the "Class Period").
Jan 27, 2021 06:17 pm ET
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $50,000 to Contact the Firm
SAN DIEGO, Jan. 27, 2021 /PRNewswire/ -- Johnson Fistel, LLP, announces that class action lawsuits have commenced on behalf of shareholders of the publicly-traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving as lead
Jan 27, 2021 10:30 am ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 26, 2021 02:11 pm ET
DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action,...
Jan 26, 2021 11:45 am ET
DEADLINE ALERT for CVIAQ, QIWI, KNDI, and GDRX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 26, 2021 02:06 am ET
Pomerantz Law Firm Announces the Filing of a Class Action against GoodRx Holdings, Inc. and Certain Officers - GDRX
NEW YORK, Jan. 26, 2021 /CNW/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) and certain of its officers.   The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00175, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise, acquired GoodRx securities between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), seeking to recover damages caused by Defend
Jan 26, 2021 02:06 am ET
Pomerantz Law Firm Announces the Filing of a Class Action against GoodRx Holdings, Inc. and Certain Officers - GDRX
NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) and certain of its officers.   The class action, filed in United States District Court for the Central District of California, and docketed under 21-cv-00175, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise, acquired GoodRx securities between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), seeking to recover damages caused by
Jan 25, 2021 04:45 pm ET
ROSEN, TOP RANKED INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – GDRX
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021...
Jan 25, 2021 09:58 am ET
GDRX FEB 9 DATE ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.– GDRX
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020, inclusive (the “Class Period”). The...
Jan 22, 2021 11:30 am ET
DEADLINE ALERT for GDRX, TRIT, ACMR, and QSR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 21, 2021 12:00 pm ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 21, 2021 11:00 am ET
KNDI, QIWI & GDRX Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Shareholders to Contact the Firm
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jan 21, 2021 08:00 am ET
GoodRX Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021
PHILADELPHIA, Jan. 21, 2021 /PRNewswire/ -- Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. ("GoodRx" or the "Company") on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the "Class Period").
Jan 20, 2021 09:34 am ET
Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action, go...
Jan 19, 2021 09:00 pm ET
GDRX FEB 9 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.– GDRX
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020, inclusive (the “Class Period”). The...
Jan 19, 2021 11:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or...
Jan 17, 2021 10:00 am ET
ROSEN, A LEADING LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GDRX
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021...
Jan 14, 2021 12:00 pm ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR : Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 13, 2021 03:45 pm ET
ROSEN, LEADING AND RESPECTED INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action - GDRX
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.
Jan 13, 2021 11:35 am ET
Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action, go...
Jan 12, 2021 11:57 am ET
GDRX FEB 9 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.– GDRX
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020, inclusive (the “Class Period”). The...
Jan 12, 2021 11:00 am ET
DEADLINE ALERT for GDRX, TRIT, ACMR, and QSR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 11, 2021 07:15 pm ET
ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Conta
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021...
Jan 11, 2021 10:00 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) Class A common stock between September 23, 2020 and November 16, 2020 inclusive (the "Class Period"). GoodRx investors have until February 16, 2021 to file a lead plaintiff motion.
Jan 09, 2021 02:45 pm ET
ROSEN, A TOP RANKED LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action – GDRX
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period"), of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.
Jan 08, 2021 10:06 am ET
GDRX DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against  GoodRx Holdings, Inc. – GDRX
Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of  GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action, go...
Jan 08, 2021 09:30 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, Jan. 8, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jan 07, 2021 05:49 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:...
Jan 07, 2021 03:09 pm ET
GoodRx Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against GoodRx Holdings, Inc. (NASDAQ: GDRX); Lead Plaintiff Deadline is February 16, 2021
PHILADELPHIA, Jan. 7, 2021 /PRNewswire/ -- Berger Montague is investigating potential securities fraud claims against GoodRx Holdings, Inc. ("GoodRx" or the "Company") on behalf of investors who purchased GoodRx securities (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020 (the "Class Period").
Jan 07, 2021 10:00 am ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
BENSALEM, Pa. ­­, Jan. 7, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) Class A common stock between September 23, 2020 and November 16, 2020, inclusive (the "Class Period").
Jan 06, 2021 01:27 pm ET
GDRX INVESTOR DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.– GDRX
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020, inclusive (the “Class Period”). The...
Jan 06, 2021 12:00 pm ET
DEADLINE ALERT for GDRX, TRIT, ACMR, QSR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 05, 2021 11:00 am ET
DEADLINE ALERT for GDRX, ACMR, and QSR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jan 05, 2021 10:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
LOS ANGELES, Jan. 5, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) Class A common stock between September 23, 2020 and November 16, 2020 inclusive (the "Class Period").
Jan 04, 2021 05:05 pm ET
GoodRx to Present Virtually at Upcoming Investor Conferences
GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform in the United States, today announced that executives from the Company will be presenting at the following virtual investor conferences:
Jan 01, 2021 05:00 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 31, 2020 12:34 pm ET
GDRX SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...
Dec 29, 2020 12:16 pm ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Law Offices of Howard G. Smith reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) Class A common stock between September 23, 2020 and Novembe
Dec 29, 2020 11:00 am ET
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired GoodRx securities between September 23, 2020 to November 16, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:
Dec 28, 2020 07:14 pm ET
ROSEN, LEADING INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important February 16 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact th
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the "Class Period") of the important February 16, 2021 lead...
Dec 28, 2020 12:30 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 16, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 26, 2020 10:00 am ET
ROSEN, A TOP RANKED LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - GDRX
NEW YORK, Dec. 26, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the "Class Period") of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.
Dec 24, 2020 12:16 pm ET
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Has Been Filed Against GoodRx Holdings, Inc. and Encourages Investors to Contact the Firm Before February 16, 2021
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 23, 2020 01:18 pm ET
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds GoodRx Holdings, Inc. Investors of Important Deadline in Securities Class Action– GDRX
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the "Class Period") of the important February 16, 2021 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.
Dec 23, 2020 11:15 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 23, 2020 11:00 am ET
GDRX Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies GoodRx Holdings, Inc. Investors of Class Action and Lead Plaintiff Deadline: February 16, 2021
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) and certain of its officers, on behalf of shareholders...
Dec 23, 2020 10:55 am ET
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against GoodRX Holdings, Inc.
Federman & Sherwood announces that on December 18, 2020, a class action lawsuit was filed in the United States District Court for the Central District of California against GoodRX Holdings, Inc. (NASDAQ: GDRX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is September 23, 2020 through November 16, 2020.
Dec 23, 2020 08:16 am ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Fi
LOS ANGELES, Dec. 23, 2020 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Dec 22, 2020 03:00 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) Class A common stock between September 23, 2020 and November 16, 2020 inclusive (the “Class Period”). GoodRx investors have until February 16, 2021
Dec 22, 2020 12:37 pm ET
ROSEN, LEADING INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the...
Dec 22, 2020 12:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 22, 2020 12:00 pm ET
GoodRx Celebrated for Culture and Leadership With Four Comparably Awards
GoodRx (Nasdaq: GDRX), America’s leading source for healthcare savings, today announced recognition from workplace culture site Comparably for its company culture and leadership. GoodRx was selected out of 60,000 companies across the U.S. and won across all four of this quarter’s categories including
Dec 21, 2020 09:01 pm ET
ROSEN, A TRUSTED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against GoodRx Holdings, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - GDRX
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 to November 16, 2020, inclusive (the "Class Period"). The lawsuit seeks to recover damages for GoodRx investors under the federal securities laws.
Dec 21, 2020 07:45 pm ET
Portnoy Law: Lawsuit Filed On Behalf of GoodRx Holdings, Inc. Investors
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of GoodRx Holdings, Inc. ("GoodRx" or "the Company") (NASDAQ: GDRX) investors that acquired securities between September 23, 2020 to November 16, 2020....
Dec 21, 2020 05:46 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc. (GDRX)
Gainey McKenna & Egleston announces that a class action lawsuit has been filed against GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) in the United States District Court for the Central District of California on behalf of those...
Dec 21, 2020 05:27 pm ET
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against GoodRx Holdings, Inc.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 21, 2020 05:05 pm ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against GoodRx Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against GoodRx Holdings, Inc. (“GoodRx” or “the Company”) (NASDAQ:
Dec 21, 2020 02:00 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of GoodRx Holdings, Inc. (GDRX) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ:
Dec 21, 2020 01:39 pm ET
GDRX INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of GoodRx Holdings, Inc. ("GoodRx" or the "Company") (NASDAQ: GDRX) from September 23, 2020 through November 16, 2020 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.